| Literature DB >> 32035997 |
G Kampf1, D Todt2, S Pfaender2, E Steinmann2.
Abstract
Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.Entities:
Keywords: Biocidal agents; Chemical inactivation; Coronavirus; Disinfection; Inanimate surfaces; Persistence
Mesh:
Substances:
Year: 2020 PMID: 32035997 PMCID: PMC7132493 DOI: 10.1016/j.jhin.2020.01.022
Source DB: PubMed Journal: J Hosp Infect ISSN: 0195-6701 Impact factor: 3.926
Persistence of coronaviruses on different types of inanimate surfaces
| Type of surface | Virus | Strain / isolate | Inoculum (viral titer) | Temperature | Persistence | Reference |
|---|---|---|---|---|---|---|
| Steel | MERS-CoV | Isolate HCoV-EMC/2012 | 105 | 20°C | 48 h | [ |
| TGEV | Unknown | 106 | 4°C | ≥ 28 d | [ | |
| MHV | Unknown | 106 | 4°C | ≥ 28 d | [ | |
| HCoV | Strain 229E | 103 | 21°C | 5 d | [ | |
| Aluminium | HCoV | Strains 229E and OC43 | 5 x 103 | 21°C | 2–8 h | [ |
| Metal | SARS-CoV | Strain P9 | 105 | RT | 5 d | [ |
| Wood | SARS-CoV | Strain P9 | 105 | RT | 4 d | [ |
| Paper | SARS-CoV | Strain P9 | 105 | RT | 4–5 d | [ |
| SARS-CoV | Strain GVU6109 | 106 | RT | 24 h | [ | |
| Glass | SARS-CoV | Strain P9 | 105 | RT | 4 d | [ |
| HCoV | Strain 229E | 103 | 21°C | 5 d | [ | |
| Plastic | SARS-CoV | Strain HKU39849 | 105 | 22°-25°C | ≤ 5 d | [ |
| MERS-CoV | Isolate HCoV-EMC/2012 | 105 | 20°C | 48 h | [ | |
| SARS-CoV | Strain P9 | 105 | RT | 4 d | [ | |
| SARS-CoV | Strain FFM1 | 107 | RT | 6–9 d | [ | |
| HCoV | Strain 229E | 107 | RT | 2–6 d | [ | |
| PVC | HCoV | Strain 229E | 103 | 21°C | 5 d | [ |
| Silicon rubber | HCoV | Strain 229E | 103 | 21°C | 5 d | [ |
| Surgical glove (latex) | HCoV | Strains 229E and OC43 | 5 x 103 | 21°C | ≤ 8 h | [ |
| Disposable gown | SARS-CoV | Strain GVU6109 | 106 | RT | 2 d | [ |
| Ceramic | HCoV | Strain 229E | 103 | 21°C | 5 d | [ |
| Teflon | HCoV | Strain 229E | 103 | 21°C | 5 d | [ |
MERS = Middle East Respiratory Syndrome; HCoV = human coronavirus; TGEV = transmissible gastroenteritis virus; MHV = mouse hepatitis virus; SARS = Severe Acute Respiratory Syndrome; RT = room temperature.
Inactivation of coronaviruses by different types of biocidal agents in suspension tests
| Biocidal agent | Concentration | Virus | Strain / isolate | Exposure time | Reduction of viral infectivity (log10) | Reference |
|---|---|---|---|---|---|---|
| Ethanol | 95% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 5.5 | [ |
| 85% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 5.5 | [ | |
| 80% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 4.3 | [ | |
| 80% | MERS-CoV | Strain EMC | 30 s | > 4.0 | [ | |
| 78% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 5.0 | [ | |
| 70% | MHV | Strains MHV-2 and MHV-N | 10 min | > 3.9 | [ | |
| 70% | CCV | Strain I-71 | 10 min | > 3.3 | [ | |
| 2-Propanol | 100% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 3.3 | [ |
| 75% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 4.0 | [ | |
| 75% | MERS-CoV | Strain EMC | 30 s | ≥ 4.0 | [ | |
| 70% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 3.3 | [ | |
| 50% | MHV | Strains MHV-2 and MHV-N | 10 min | > 3.7 | [ | |
| 50% | CCV | Strain I-71 | 10 min | > 3.7 | [ | |
| 2-Propanol and 1-propanol | 45% and 30% | SARS-CoV | Isolate FFM-1 | 30 s | ≥ 4.3 | [ |
| SARS-CoV | Isolate FFM-1 | 30 s | ≥ 2.8 | [ | ||
| Benzalkonium chloride | 0.2% | HCoV | ATCC VR-759 (strain OC43) | 10 min | 0.0 | [ |
| 0.05% | MHV | Strains MHV-2 and MHV-N | 10 min | > 3.7 | [ | |
| 0.05% | CCV | Strain I-71 | 10 min | > 3.7 | [ | |
| 0.00175% | CCV | Strain S378 | 3 d | 3.0 | [ | |
| Didecyldimethyl ammonium chloride | 0.0025% | CCV | Strain S378 | 3 d | > 4.0 | [ |
| Chlorhexidine digluconate | 0.02% | MHV | Strains MHV-2 and MHV-N | 10 min | 0.7–0.8 | [ |
| 0.02% | CCV | Strain I-71 | 10 min | 0.3 | [ | |
| Sodium hypochlorite | 0.21% | MHV | Strain MHV-1 | 30 s | ≥ 4.0 | [ |
| 0.01% | MHV | Strains MHV-2 and MHV-N | 10 min | 2.3–2.8 | [ | |
| 0.01% | CCV | Strain I-71 | 10 min | 1.1 | [ | |
| 0.001% | MHV | Strains MHV-2 and MHV-N | 10 min | 0.3–0.6 | [ | |
| 0.001% | CCV | Strain I-71 | 10 min | 0.9 | [ | |
| Hydrogen peroxide | 0.5% | HCoV | Strain 229E | 1 min | > 4.0 | [ |
| Formaldehyde | 1% | SARS-CoV | Isolate FFM-1 | 2 min | > 3.0 | [ |
| 0.7% | SARS-CoV | Isolate FFM-1 | 2 min | > 3.0 | [ | |
| 0.7% | MHV | 10 min | > 3.5 | [ | ||
| 0.7% | CCV | Strain I-71 | 10 min | > 3.7 | [ | |
| 0.009% | CCV | 24 h | > 4.0 | [ | ||
| Glutardialdehyde | 2.5% | SARS-CoV | Hanoi strain | 5 min | > 4.0 | [ |
| 0.5% | SARS-CoV | Isolate FFM-1 | 2 min | > 4.0 | [ | |
| Povidone iodine | 7.5% | MERS-CoV | Isolate HCoV-EMC/2012 | 15 s | 4.6 | [ |
| 4% | MERS-CoV | Isolate HCoV-EMC/2012 | 15 s | 5.0 | [ | |
| 1% | SARS-CoV | Hanoi strain | 1 min | > 4.0 | [ | |
| 1% | MERS-CoV | Isolate HCoV-EMC/2012 | 15 s | 4.3 | [ | |
| 0.47% | SARS-CoV | Hanoi strain | 1 min | 3.8 | [ | |
| 0.25% | SARS-CoV | Hanoi strain | 1 min | > 4.0 | [ | |
| 0.23% | SARS-CoV | Hanoi strain | 1 min | > 4.0 | [ | |
| 0.23% | SARS-CoV | Isolate FFM-1 | 15 s | ≥ 4.4 | [ | |
| 0.23% | MERS-CoV | Isolate HCoV-EMC/2012 | 15 s | ≥ 4.4 | [ |
SARS = Severe Acute Respiratory Syndrome; MERS = Middle East Respiratory Syndrome; MHV = mouse hepatitis virus; CCV = canine coronavirus; HCoV = human coronavirus.
Inactivation of coronaviruses by different types of biocidal agents in carrier tests
| Biocidal agent | Concentration | Virus | Strain / isolate | Volume / material | Organic load | Exposure time | Reduction of viral infectivity (log10) | Reference |
|---|---|---|---|---|---|---|---|---|
| Ethanol | 71% | TGEV | Unknown | 50 μl / stainless steel | None | 1 min | 3.5 | [ |
| 71% | MHV | Unknown | 50 μl / stainless steel | None | 1 min | 2.0 | [ | |
| 70% | TGEV | Unknown | 50 μl / stainless steel | None | 1 min | 3.2 | [ | |
| 70% | MHV | Unknown | 50 μl / stainless steel | None | 1 min | 3.9 | [ | |
| 70% | HCoV | Strain 229E | 20 μl / stainless steel | 5% serum | 1 min | > 3.0 | [ | |
| 62% | TGEV | Unknown | 50 μl / stainless steel | None | 1 min | 4.0 | [ | |
| 62% | MHV | Unknown | 50 μl / stainless steel | None | 1 min | 2.7 | [ | |
| Benzalkoniumchloride | 0.04% | HCoV | Strain 229E | 20 μl / stainless steel | 5% serum | 1 min | < 3.0 | [ |
| Sodium hypochlorite | 0.5% | HCoV | Strain 229E | 20 μl / stainless steel | 5% serum | 1 min | > 3.0 | [ |
| 0.1% | HCoV | Strain 229E | 20 μl / stainless steel | 5% serum | 1 min | > 3.0 | [ | |
| 0.06% | TGEV | Unknown | 50 μl / stainless steel | None | 1 min | 0.4 | [ | |
| 0.06% | MHV | Unknown | 50 μl / stainless steel | None | 1 min | 0.6 | [ | |
| 0.01% | HCoV | Strain 229E | 20 μl / stainless steel | 5% serum | 1 min | < 3.0 | [ | |
| Glutardialdehyde | 2% | HCoV | Strain 229E | 20 μl / stainless steel | 5% serum | 1 min | > 3.0 | [ |
| Ortho-phtalaldehyde | 0.55% | TGEV | Unknown | 50 μl / stainless steel | None | 1 min | 2.3 | [ |
| 0.55% | MHV | Unknown | 50 μl / stainless steel | None | 1 min | 1.7 | [ | |
| Hydrogen peroxide | Vapor of unknown concentration | TGEV | Purdue strain type 1 | 20 μl / stainless steel | None | 2–3 h | 4.9–5.3* | [ |
TGEV = transmissible gastroenteritis virus; MHV = mouse hepatitis virus; HCoV = human coronavirus; *depending on the volume of injected hydrogen peroxide.